¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå º¸°í¼­ : À¯Çü, ±â¼ú, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°(2025-2033³â)
Radiation Oncology Market Report by Type, Technology, Application, End User, and Region 2025-2033
»óǰÄÚµå : 1722404
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 137 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,177,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,569,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 6,962,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå ±Ô¸ð´Â 2024³â 86¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2033³â±îÁö 149¾ï ´Þ·¯¿¡ ´ÞÇϰí, 2025-2033³â 6.3%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î Àü¸ÁÇϰí ÀÖ½À´Ï´Ù. ±â¼ú ¹ßÀü, ¾Ï ¹ßº´·ü Áõ°¡, Á¾¾ç ¹æ»ç¼±¿¡ ´ëÇÑ ÀÎ½Ä °³¼±, Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê, °øµ¿ ¿¬±¸, ±ÔÁ¦ ´ç±¹ÀÇ »õ·Î¿î Ä¡·á¹ý ½ÂÀÎ, °³ÀÎ ¸ÂÃãÇü ÀÇ·á Æ®·»µå µîÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎ Áß ÀϺÎÀÔ´Ï´Ù.

¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå ºÐ¼® :

ÁÖ¿ä ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ : ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº Àü ¼¼°èÀûÀ¸·Î ±ÞÁõÇÏ´Â ¾Ï À¯º´·ü°ú °°Àº ¿äÀÎÀÔ´Ï´Ù. È¿°úÀûÀ̰í Á¤È®ÇÑ Ä¡·á¹ý¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä°¡ ¿µ»ó À¯µµ ¹æ»ç¼± Ä¡·á¿Í ¾ç¼ºÀÚ Ä¡·áÀÇ °³¹ßÀ» ÃËÁøÇÏ°í ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ Ãß¼¼´Â Åë°èÀûÀ¸·Î ¾Ï¿¡ °É¸®±â ½¬¿î ³ëÀÎ Àα¸ Áõ°¡ÀÔ´Ï´Ù. ¶ÇÇÑ, ƯÈ÷ °³¹ßµµ»ó±¹¿¡¼­ÀÇ ÀÇ·á¼¾ÅÍ °³Ã´¿¡ ´ëÇÑ ÅõÀÚ¿Í Á¤ºÎ ¹× ¹Î°£ÀÇ ¾Ï °ËÁø ¹× ¿¹¹æ ÀÌ´Ï¼ÅÆ¼ºêÀÇ È°¿ëÀÌ ¹æ»ç¼±Á¾¾çÇÐ ½ÃÀå Á¡À¯À²À» ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ¿¬±¸ ±â°ü°ú ±â¾÷µéÀº Çõ½ÅÀûÀÎ ¹æ»ç¼± Ä¡·á¹ý °³¹ßÀ» À§ÇØ Àû±ØÀûÀ¸·Î Çù·ÂÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå µ¿Çâ : ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀåÀÇ ÁÖ¿ä Æ®·»µå Áß Çϳª´Â °í¼±·®ÀÇ ¹æ»ç¼±À» ¿©·¯ ¹ø ³ª´©¾î Á¶»çÇÏ´Â ÀúºÐÇÒ ¿ä¹ýÀ̳ª ÃÊÀúºÐÇÒ ¿ä¹ýÀ¸·ÎÀÇ ÀüȯÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº ȯÀÚ¿¡°Ô ´õ Æí¸®Çϰí ÀÇ·áºñ Àý°¨¿¡µµ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ, Ä¡·á °èȹ ½Ã½ºÅÛ¿¡¼­ ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×(ML)ÀÇ È°¿ëÀÌ È®´ëµÇ°í ÀÖÀ¸¸ç, ±âÁ¸ ½Ã½ºÅÛº¸´Ù ÁÖº¯ °Ç°­ÇÑ Á¶Á÷¿¡ ´ëÇÑ ¼Õ»óÀ» ÁÙÀ̸鼭 ȯºÎ¿¡ ´õ Á¤È®ÇÏ°Ô ¹æ»ç¼±À» Á¶»çÇÏ´Â ¸ÂÃãÇü Åõ¿© ÆÐÅÏÀÌ »ý¼ºµÇ¾î ½ÃÀå ¼ºÀåÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹æ»ç¼± Ä¡·á¿Í ¼ö¼ú, È­Çпä¹ý, ¸é¿ª¿ä¹ý µî ´Ù¸¥ Ä¡·á¹ýÀ» º´ÇàÇÏ´Â ¸ÖƼ¸ð´Þ¸®Æ¼ Ä¡·á´Â Ä¡·á °á°ú¸¦ ´õ¿í Çâ»ó½ÃŰ´Â µ¥ ±â¿©Çϰí ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î ȯÀÚÀÇ »îÀÇ Áú¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ÃÖ¼ÒÈ­ÇÏ´Â Ä¡·á ½ºÄÉÁÙ¸µ Áõ°¡ Ãß¼¼µµ ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

Áö¸®Àû µ¿Çâ : ÇöÀç ¼¼°è ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀåÀÇ ¼±µÎ¸¦ ´Þ¸®°í ÀÖ´Â Áö¿ªÀº ºÏ¹ÌÀÔ´Ï´Ù. ÀÌ Áö¿ªÀÇ ¿ìÀ§¿¡´Â ÷´Ü ÀÇ·á ÀÎÇÁ¶ó, ³ôÀº ÀÇ·áºñ, Àú¸íÇÑ Àåºñ Á¦Á¶¾÷üÀÇ Á¸Àç µî ¿©·¯ °¡Áö ¿äÀÎÀÌ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ Áö¿ªÀÇ ³ôÀº ½ÃÀå ÁöÀ§´Â Ȱ¹ßÇÏ°Ô ÁøÇàµÇ°í ÀÖ´Â ¿¬±¸¿Í ¾ç¼ºÀÚ Ä¡·á ¼¾ÅÍ¿Í °°Àº ½Å±â¼úÀÇ ³ôÀº äÅ÷ü¿¡ ±âÀÎÇÕ´Ï´Ù. ¶ÇÇÑ, ¾Ï Ä¡·áÀÇ Áú°ú Á¢±Ù¼ºÀÇ Á߿伺À» °­Á¶ÇÏ´Â ¾ö°ÝÇÑ ÀÇ·á Á¤Ã¥°ú ´ë±Ô¸ð °øÁߺ¸°Ç ÇÁ·Î±×·¥ÀÌ À¯·´ ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå ºÐ¼®¿¡ µû¸£¸é, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¶°¿À¸£´Â Áö¿ªÀÔ´Ï´Ù. ÀÇ·áºñ ÁöÃâÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ¾Ï¿¡ ´ëÇÑ Àνĵµ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. Áß±¹, Àεµ µî¿¡¼­´Â ÀÇ·á ½Ã¼³ÀÇ °³¼±ÀÌ ÁøÇàµÇ°í ÀÖ½À´Ï´Ù.

°æÀï ±¸µµ : ½ÃÀå °æÀï ±¸µµ´Â Accuray Incorporated,Becton Dickinson and Company,Canon Inc.,Elekta,Hitachi, Hitachi, Icad Inc. Medical Systems Inc., Nordion£¨Canada£©Inc.(Sotera Health), P-Cure Ltd.¿¡ ÀÇÇØ Ư¡Áö¾îÁý´Ï´Ù.

°úÁ¦¿Í ±âȸ: ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀåÀº ÷´Ü ¹æ»ç¼± Ä¡·á ½Ã½ºÅÛ°ú °ü·ÃµÈ ³ôÀº ºñ¿ë°ú °°Àº ¹®Á¦¿¡ Á÷¸éÇØ ÀÖÀ¸¸ç, ÀÌ´Â ºÎÀ¯ÇÏÁö ¾ÊÀº Áö¿ª¿¡¼­ ½ÃÀå ħÅõ¸¦ Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Å±â¼úÀÇ ½ÂÀο¡ ¸¹Àº ½Ã°£°ú ºñ¿ëÀÌ ¼Ò¿äµÇ±â ¶§¹®¿¡ ±ÔÁ¦»óÀÇ Àå¾Ö¹°µµ Å« µµÀüÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÅÈï ½ÃÀå¿¡¼­´Â ¼÷·ÃµÈ Àü¹®°¡°¡ ºÎÁ·ÇÏ¿© ÷´Ü Ä¡·á¹ýÀÇ µµÀÔ¿¡ °É¸²µ¹ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÌ·¯ÇÑ µµÀüÀº ±âȸÀ̱⵵ ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, ºñ¿ë È¿À²ÀûÀÎ ¹æ»ç¼± Ä¡·á ÀåºñÀÇ °³¹ßÀº Àú¼Òµæ ±¹°¡ ½ÃÀå ÁøÃâ¿¡ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾Ï Ä¡·á Àü¹®°¡¸¦ À§ÇÑ ±³À° ÀÌ´Ï¼ÅÆ¼ºê¿Í ÈÆ·Ã ÇÁ·Î±×·¥Àº ÀÚ°ÝÀ» °®Ãá Àü¹®°¡ ºÎÁ·À» ¿ÏÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¹æ»ç¼±Á¾¾çÇÐ ½ÃÀå µ¿Çâ :

±â¼ú ¹ßÀü

¼¼°è ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â Áö¼ÓÀûÀ¸·Î ¹ßÀüÇÏ´Â ±â¼úÀÔ´Ï´Ù. °­µµÁ¶Àý ¹æ»ç¼± Ä¡·á(IMRT)¿Í ¿µ»ó À¯µµ ¹æ»ç¼± Ä¡·á(IGRT)ÀÇ Åº»ýÀ» Æ÷ÇÔÇÑ ±â¼ú °³¹ßÀº ¾Ï Ä¡·á¸¦ ÀçÁ¤ÀÇÇÏ°í ´Ù¸¥ °Ç°­ÇÑ ½Åü ¼¼Æ÷ÀÇ ¼Õ»óÀ» ÃÖ¼ÒÈ­Çϸ鼭 Á¾¾çÀ» º¸´Ù Á¤È®ÇÏ°Ô Ç¥ÀûÈ­ÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ¿¹¸¦ µé¾î, IMRT´Â Á¶»çÇÏ´Â ¹æ»ç¼±·®À» Á¶ÀýÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ±â¼úÀ» ÅëÇØ Á¾¾ç Àü¹®ÀÇ´Â ÁÖº¯ °Ç°­ÇÑ Á¶Á÷ÀÇ ÆÄ±«¸¦ ÃÖ¼ÒÈ­Çϸ鼭 Á¾¾çÀÇ º¹ÀâÇÑ ÇüÅ¿¡ ¸Â°Ô ¹æ»ç¼± ºöÀ» Á¶Á¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹Ý¸é, IGRT´Â CT ½ºÄµÀ̳ª MRI¿Í °°Àº Ư¼ö ¿µ»óÀ» ÀÌ¿ëÇÏ¿© °¢ Ä¡·á ¼¼¼Ç Àü¿¡ Á¾¾çÀÇ Á¤È®ÇÑ À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, IGRT´Â Á¾¾çÀÇ °íÈ­Áú ¿µ»óÀ» ¾òÀ» ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, °Ë»ç À§Ä¡¸¦ È®ÀÎÇÏ°í ¿©·¯ ±â°èÈ­µÈ ¹æ»ç¼± ºöÀ» ÀÌ¿ëÇÑ Ä¡·á°¡ °¡´ÉÇÕ´Ï´Ù. ¶ÇÇÑ, Ãø¸é Ä¡·áÀÇ ¹ßÀüÀ¸·Î ¾ç¼ºÀÚ¼± Ä¡·á°¡ ¹ß¸íµÇ¾ú½À´Ï´Ù. ÀÌ Ä¡·á¹ýÀº ±âÁ¸ÀÇ ¿¢½º·¹ÀÌ ´ë½Å °í¿¡³ÊÁöÀÇ ¾ç¼ºÀÚ¼±À¸·Î ¹æ»ç¼±À» Á¶»çÇÏ´Â °ÍÀ¸·Î, ºÎÀÛ¿ëÀ» ÃÖ¼ÒÈ­Çϸ鼭 ¿ì¼öÇÑ ¼±·® ÁýÁßÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â¿¡´Â ÇÙ¹«±â °ü·Ã °úÇÐ ±â°üÀ» Áß½ÉÀ¸·Î ÇÑ Áß±¹ ¿¬±¸ ±×·ìÀÌ Ç÷¡½Ã¶ó´Â °­·ÂÇÑ ¹æ»ç¼± Á¶»ç ½Ã½ºÅÛÀ» ¼³°èÇß½À´Ï´Ù. ÃÊ°í¿¡³ÊÁö ¹æ»ç¼±À» Á¶»çÇÒ ¼ö ÀÖ´Â ÀÌ ½Ã½ºÅÛÀº ±âÁ¸ ¹æ»ç¼± Ä¡·áÀÇ ÆÇµµ¸¦ µÚ¹Ù²Ü ¼ö ÀÖ´Â ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù.

¾Ï ¹ßº´·ü »ó½Â

¼¼°è ¹æ»ç¼±Á¾¾çÇÐ ½ÃÀåÀº ÁÖ·Î ½ÅÈï±¹À» Áß½ÉÀ¸·Î Àü ¼¼°è ¾Ï ¹ß»ý·ü Áõ°¡·Î ÀÎÇØ Ȱ¼ºÈ­µÇ°í ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, 2022³â Àεµ¿¡¼­ 1,410¸¸ ¸í ÀÌ»óÀÇ ¾ÏÀÌ »õ·Î ¹ß»ýÇϰí 910¸¸ ¸í ÀÌ»óÀÌ ¾ÏÀ¸·Î ÀÎÇØ »ç¸ÁÇÒ °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù. À¯¹æ¾ÏÀº Àü ¼¼°è Áúº´ ¹ß»ýÀÇ ÁöÇ¥·Î °¡Àå ¸¹ÀÌ È®Àεǰí ÀÖÀ¸¸ç, ½Å±Ô Áúº´ÀÇ 10ºÐÀÇ 1 ÀÌ»óÀ» Â÷ÁöÇÕ´Ï´Ù. ¾ÏÀÇ À¯º´·üÀº ³ëÈ­¿Í ÇÔ²² Áõ°¡Çϸç, ¿À·£ ±â°£ µ¿¾È ¾Ë·ÁÁø ±âȸÀÇ º¯È­¿Í ȯ°æÀÇ º¯È­µµ ¾Ï ¹ßº´·üÀ» ´õ¿í Áõ°¡½ÃŰ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¹æ»ç¼± Á¾¾çÇп¡ ´ëÇÑ ¼ö¿ä´Â ±¹Á¦ÀûÀ¸·Î °¡Àå ÈçÇÑ »ç¸Á ¿øÀÎ Áß Çϳª°¡ µÉ °ÍÀ¸·Î ¿¹»óµÇ´Â ¾Ï ȯÀÚ Áõ°¡·Î ÀÎÇØ ´õ¿í Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ÀÎ½Ä Á¦°í¿Í Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê

¾ÏÀÇ Á¶±â Áø´Ü°ú Á¶±â Ä¡·áÀÇ Á߿伺¿¡ ´ëÇÑ Áö½Ä Áõ°¡, ¾Ï ȯÀÚ°¡ ¾çÁúÀÇ Ä¡·á¸¦ ¹ÞÀ» ¼ö ÀÖµµ·Ï °ø°ø ºÎ¹®ÀÇ Àû±ØÀûÀÎ ³ë·Â°ú ÀÚ¿ø ¹èºÐÀº ¹æ»ç¼± Á¾¾çÇÐ ºÐ¾ßÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ ºñÁ¤ºÎ±â±¸(NGO)¿Í ±¹Á¦±â±¸´Â ¾Ï¿¡ ´ëÇÑ È¯ÀÚµéÀÇ ÀνÄÀ» ³ôÀÌ°í ¹æ»ç¼± Ä¡·á ¼­ºñ½ºÀÇ Çʿ伺À» ³ôÀ̱â À§ÇØ ´Ù¾çÇÑ ÀÎ½Ä °³¼± ÇÁ·Î±×·¥°ú Ä·ÆäÀÎÀ» ÁøÇàÇϰí ÀÖ½À´Ï´Ù. Á¤ºÎ ÀÇ·á±â°üµµ ¹æ»ç¼± ¼­ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» °­È­ÇÏ°í ¾Ï ºÎ´ãÀ» ÁÙÀ̱â À§ÇØ ¾Ï ´ëÃ¥, ½Ã¼³ °³¹ß, ÁöºÒ Á¦µµ¿¡ ÅõÀÚÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå Àü¸ÁÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼­·Ð

Á¦5Àå ¼¼°èÀÇ ¹æ»ç¼± Á¾¾çÇÐ ½ÃÀå

Á¦6Àå ½ÃÀå ºÐ¼® : À¯Çüº°

Á¦7Àå ½ÃÀå ºÐ¼® : ±â¼úº°

Á¦8Àå ½ÃÀå ºÐ¼® : ¿ëµµº°

Á¦9Àå ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦11Àå SWOT ºÐ¼®

Á¦12Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦13Àå PorterÀÇ Five Forces ºÐ¼®

Á¦14Àå °¡°Ý ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global radiation oncology market size reached USD 8.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 14.9 Billion by 2033, exhibiting a growth rate (CAGR) of 6.3% during 2025-2033. Technological advancements, rising cancer incidence, increasing awareness regarding oncology radiation, government initiatives, and collaborations, regulatory approvals for new therapies, and the trend towards personalized medicine are some of the factors fostering the market growth.

Radiation Oncology Market Analysis:

Major Market Drivers: The radiation oncology market growth is fueled by the factors, including the surging prevalence of cancer across the globe. The high demand for effective and accurate treatment methods prompts the development of image-guided radiation therapy and proton therapy, which is further stimulating the market growth. Another trend is also the rise in the number of geriatric population that is statistically more prone to cancer. In addition, investments in the development of medical centers, especially in developing countries, and availability of government and private cancer screening and prevention initiatives are driving the radiation oncology market share. In line with this, research institutions and companies are actively joining forces for the development of innovative radiation therapies, which is favoring the market growth.

Key Market Trends: One of the key radiation oncology market trends is the shift toward hypofractionated and ultra-hypofractionated therapies, in which higher doses of radiation are given over few sessions. This approach is convenient for patients and reduces medical expenditures. Moreover, the use of artificial intelligence (AI) and machine learning (ML) in treatment planning systems is growing, producing more tailored administration patterns which deliver radiation more precisely to the affected location than traditional systems while reducing damage to surrounding healthy tissue, which is accelerating the market growth. Furthermore, multimodality treatments continue to provide a boon, combining radiation therapy with other treatments like surgery, chemotherapy, and immunotherapy, which further improves therapeutic outcomes. Apart from this, the growing trend towards therapeutic scheduling that minimizes the impact of the therapy on the patient's quality of life is driving the radiation oncology market growth.

Geographical Trends: At present, North America is at the forefront of the world's radiation oncology market. Several factors contribute to this region's dominance, including the advanced healthcare infrastructure, high healthcare spending, and the presence of prominent device manufacturers. The region's strong market position also stems from research being pursued aggressively and high rates of new technology adoption, such as proton therapy centers. Moreover, Europe's market expansion is driven by stringent healthcare policies and large-scale public health programs that stress the importance of cancer treatment quality and accessibility. As per the radiation oncology market analysis, the Asia-Pacific is an up-and-coming region. Healthcare spending is on the rise, and cancer awareness is growing. The healthcare facilities are becoming more advanced in countries such as China and India.

Competitive Landscape: The competitive landscape of the market is characterized by the presence of key radiation oncology companies, such as Accuray Incorporated, Becton Dickinson and Company, Canon Inc., Elekta, Hitachi Ltd., Icad Inc., Ion Beam Applications, Isoray Inc., Mevion Medical Systems Inc., Nordion (Canada) Inc. (Sotera Health), P-Cure Ltd., Varian Medical Systems Inc. (Siemens Healthineers AG), ViewRay, etc.

Challenges and Opportunities: The radiation oncology market faces challenges such as high costs associated with advanced radiation therapy systems, which can limit market penetration in less affluent regions. Regulatory hurdles also pose significant challenges, as gaining approval for new technologies can be time-consuming and costly. Moreover, there is a shortage of skilled professionals in emerging markets, which hampers the adoption of advanced therapies. However, these challenges also present opportunities. For example, the development of cost-effective radiation therapy machines can help penetrate low-income markets. Educational initiatives and training programs for oncology care providers can alleviate the shortage of qualified professionals.

Radiation Oncology Market Trends:

Technological Advancements

One of the major factors influencing the global radiation oncology market is the continually advancing technology. Technological development, including the creation of intensity modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), have redefined the treatment of cancer, enabling more accurate targeting of tumors with minimal damage to other healthy body cells. For example, IMRT employs varied intensities in the radiation doses it administers. This technology enables oncologists to conform the radiation beams according to the complicated shape of the tumor with minimal destruction of surrounding healthy tissues. IGRT, on the other hand, utilizes specialized imagining such as CT scans or MRIs to identify the tumor's exact location before each treatment session. In addition to producing high quality images of the tumor, IGRT offers test position verification and treatment carrying out several mechanized radiation beams. Further, lateral therapy advancements have resulted in the invention of proton therapy. This therapy administers radiation with high-energy protons instead of traditional x-rays, allowing superior dose concentration with minimal side effects. For instance, in 2024, a powerful irradiation system called the Flash was designed by a Chinese research group mainly from nuclear weapons related scientific institutions. The system is capable of administering ultra-high energy radiation and has the potential to transform conventional radiotherapy.

Rising Incidence of Cancer

The global radiation oncology market is primarily fueled by an increase in cancer occurrence across the world, mainly in developing countries. According to the most recent report on the global occurrence of the disease by the World Health Organization (WHO), there were over 14.1 lakh new cancer instances and more than 9.1 lakh cancer-related deaths in India in 2022. Breast cancer was the most frequently identified measure of global occurrence of the disease, accounting for more than one-tenth of all new illnesses. The prevalence of cancer rises as people age; moreover, a change in long-known chances and the presence of longstanding environmental are additional growth factors. The radiation oncology demand is also boosted by the growing number of cancer patients, which is predicted to be one of the most common causes of death internationally.

Increasing Awareness and Government Initiatives

Rising knowledge about the importance of early cancer diagnosis and treatment, as well as public sector proactiveness and allocation of resources to ensure that cancer patients receive high-quality care, are driving the growth of radiation oncology globally. Several public awareness programs and campaigns are being implemented by various non-governmental organizations (NGOs) and international organizations to boost patient awareness of cancer and the rising need for radiation therapy services. Government health agencies are also investing in cancer control, facilities development, and payment schemes to enhance access to radiation services and reduce the cancer burden, which is further driving the radiation oncology market outlook.

Radiation Oncology Industry Segmentation:

Breakup by Type:

External beam radiation therapy (EBRT) accounts for the majority of the market share

Breakup by Technology:

Breakup by Application:

Breakup by End User:

Breakup by Region:

North America leads the market, accounting for the largest radiation oncology market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Radiation Oncology Market

6 Market Breakup by Type

7 Market Breakup by Technology

8 Market Breakup by Application

9 Market Breakup by End User

10 Market Breakup by Region

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Analysis

15 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â